Full Name
Julia Wilson
Job title
Associate Director
Affiliation
Wellcome Trust Sanger Institute
Speaker bio
Julia builds and supports the relationships needed to support the strategic vision of the Sanger Institute. These activities range from interactions with the academic scientific community, commercial partners, funders and government and policymakers.
Julia increases awareness of the Sanger Institute’s research, explores new collaborations and areas of research, strengthens and builds on existing links to accelerate and expand the impact and reach of Sanger Institute science. She works to translate the outcomes of research and position the Sanger Institute as a source of translational opportunities. In addition she raises awareness of the importance and impact of genomics research with government and policy makers and facilitates the translation of genomics research into clinical practice.
Previously Julia was Assistant Director of Research at Breakthrough Breast Cancer and Science Programme Manager at the World Cancer Research Fund. As a scientist she was a post-doc at the Karolinska Institute in Sweden and then worked as a cancer researcher for a number of years at Cancer Research UK and Queen Mary University of London.
Julia increases awareness of the Sanger Institute’s research, explores new collaborations and areas of research, strengthens and builds on existing links to accelerate and expand the impact and reach of Sanger Institute science. She works to translate the outcomes of research and position the Sanger Institute as a source of translational opportunities. In addition she raises awareness of the importance and impact of genomics research with government and policy makers and facilitates the translation of genomics research into clinical practice.
Previously Julia was Assistant Director of Research at Breakthrough Breast Cancer and Science Programme Manager at the World Cancer Research Fund. As a scientist she was a post-doc at the Karolinska Institute in Sweden and then worked as a cancer researcher for a number of years at Cancer Research UK and Queen Mary University of London.
Speaking At